奥扎格雷钠治疗急性脑梗死的临床疗效观察

目的观察奥扎格雷钠(奥邦)治疗急性脑梗死的临床疗效和安全性。方法50例急性脑梗死患者随机分为治疗组(奥扎格雷钠组)25例和对照组(复方丹参组)25例,两组患者皆为发病72h内的急性病例。两组基础治疗相同,疗程均为14d。对患者的神经功能缺损程度进行治疗前后的对照评价。结果治疗组总有效率(88.0%)明显优于对照组(68.0%),组间比较差异非常显著(P<0.05)。结论奥扎格雷钠治疗急性脑梗死疗效确切、安全可靠,值得临床推广应用。

Observation on the Effect of Ozagrel on Treating Acute Cerebral Infarction

Objective To observe the clinical effect and safety of Ozagrel on treating acute cerebral infarction. Methods 50 cases of acute cerebral infarction were randomly divided into two groups,treatment group and control group,which the former treated with Ozagrel and the latter with composite salvia miltiorrhiza.The patients of both groups were attacked by acute cerebral infarction within 72 hours and received the same general treatment.After a course of 14 days,both groups were observed on the degree of nervous function defect before and after the treatment. Results The total effective rate of trentment group (88.0%) was obviously higher than that of control group(68.0%) (P<0.05). Conclusion With safety and reliability,Ozagrel is an efficacious drug in treating acute cerebral infarction and thus worth popularizing for clinical purpose.